Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis

PURPOSE: Several studies have suggested that an HLA-Cw6+ allele can predict an improved outcome of treatment in psoriasis patients. The aim of the study was to assess whether the published association between HLA-Cw6 allele carriers and response to ustekinumab has the potential to impact treatment d...

Descripción completa

Detalles Bibliográficos
Autores principales: Anzengruber, Florian, Ghosh, Adhideb, Maul, Julia-Tatjana, Drach, Mathias, Navarini, Alexander A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919162/
https://www.ncbi.nlm.nih.gov/pubmed/29721444
http://dx.doi.org/10.2147/PTT.S161437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919162/
https://www.ncbi.nlm.nih.gov/pubmed/29721444
http://dx.doi.org/10.2147/PTT.S161437

Ejemplares similares